Post-phototherapy bilirubin rebound does occur: Destruction of a myth

被引：0
|
作者：
Kaplan, M
Hammerman, C
Schimmel, MS
Bromiker, R
Eidelman, AI
机构：
[1] Shaare Zedek Med Ctr, Jerusalem, Israel
[2] Hebrew Univ Jerusalem, IL-91905 Jerusalem, Israel
[3] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel
来源：
PEDIATRIC RESEARCH | 2003年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
2080
引用
收藏
页码：366A / 366A
页数：1
相关论文
共 47 条
  • [41] Cytotoxic Destruction of Cerebellar Purkinje Cells Following Antibody Uptake Is Specific for Anti-Yo Antibody and Does Not Occur with Anticerebellar Antibodies from Ovarian Cancer Patients Who Remain Neurologically Normal
    Greenlee, John E.
    Hill, Kenneth E.
    Clawson, Susan A.
    Carlson, Noel G.
    NEUROLOGY, 2009, 72 (11) : A27 - A27
  • [42] Post-activation performance enhancement does not occur following a large hand-paddles and parachute-resisted warm-up routine in collegiate swimmers
    Bufalo, Santiago Soares
    Fontanetti, Gabriel
    Barreto, Renan Vieira
    Benazzi, Gabriel Rocha
    Correa Junior, Rubens
    Marangoni, Victor
    de Menezes Bassan, Natalia
    Denadai, Benedito Sergio
    Greco, Camila Coelho
    Vilas-Boas, Joao Paulo
    de Lima, Leonardo Coelho Rabello
    FRONTIERS IN SPORTS AND ACTIVE LIVING, 2023, 5
  • [43] Does "wearing off" of efficacy occur in galcanezumab-treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials
    Ailani, Jessica
    Kuruppu, Dulanji K.
    Rettiganti, Mallikarjuna
    Oakes, Tina
    Schroeder, Krista
    Wietecha, Linda
    Port, Martha
    Blumenfeld, Andrew M.
    HEADACHE, 2022, 62 (02): : 198 - 207
  • [44] DOES WEARING OFF OF EFFICACY OCCUR IN GALCANEZUMAB-TREATED PATIENTS AT THE END OF THE MONTHLY TREATMENT CYCLE: A POST HOC ANALYSIS OF FOUR PHASE 3 RANDOMIZED TRIALS
    Ailani, Jessica
    Kuruppu, Dulanji K.
    Rettiganti, Mallikarjuna
    Oakes, Tina M.
    Wietecha, Linda A.
    Port, Martha D.
    Blumenfeld, Andrew M.
    CEPHALALGIA, 2020, 40 : 70 - 71
  • [45] Does wearing off of efficacy occur in galcanezumab-treated patients at the end of the monthly treatment cycle: A post hoc analysis of four phase 3 randomized trials
    Ailani, J.
    Kuruppu, D.
    Rettiganti, M.
    Oakes, T. M.
    Wietecha, L.
    Port, M. D.
    Blumenfeld, A. M.
    HEADACHE, 2021, 61 : 153 - 154
  • [46] Does Wearing-Off of Efficacy Occur in Galcanezumab-Treated Patients at the End of the Monthly Treatment Cycle: A Post Hoc Analysis of Four Phase 3 Randomized Trials
    Ailani, Jessica
    Kuruppu, Dulanji
    Rettiganti, Mallikarjuna
    Oakes, Tina
    Wietecha, Linda
    Port, Martha
    Blumenfeld, Andrew
    NEUROLOGY, 2021, 96 (15)
  • [47] Does rebound exist? A comparison of venous thromboembolic (VTE) event rates in the post-treatment period for patients randomized to long-term low-molecular-weight heparin (LMWH) versus warfarin sodium.
    Hull, RD
    Pineo, GF
    Mah, AF
    BLOOD, 2002, 100 (11) : 501A - 501A
12345